4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-011362
CVP, Chief Financial Officer sold 14,510 shares at $76.55 ($1,110,794)
- CVP, Chief Financial Officer acquired 14,510 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,510 | $36.75 | $533,243 | 33,758 | D |
| 2023-12-29 | Sale : show line 2 in the form 10b5-1 | −14,510 | $76.55 | $1,110,794 | 19,248 | D |
| Open-market sales · 14,510 sh · avg $76.55 · $1,110,794 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-12-29 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −14,510 | $36.75 | 2024-05-10 | 14,510 | 29,015 | D |
Loading xslF345X05/doc4.xml…